Clinical Trials
3 trialsNCT06562647 2026-02-13
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Phase NA Recruiting
NCT05664009 2024-04-05
The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults
Canada Royal Enoch Phytomedicine Co., Ltd.
Phase 2 Unknown
NCT00638963 2017-06-14
STOP
Merck Sharp & Dohme LLC
Phase 2 Terminated